Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study

被引:11
|
作者
Nakayama, Shingo [1 ]
Chubachi, Shotaro [1 ]
Sakurai, Kaori [1 ]
Irie, Hidehiro [1 ]
Tsutsumi, Akihiro [1 ]
Hashiguchi, Mizuha [2 ]
Itabashi, Yuji [3 ]
Murata, Mitsushige [4 ]
Nakamura, Hidetoshi [5 ]
Asano, Koichiro [6 ]
Fukunaga, Koichi [1 ]
机构
[1] Keio Univ, Dept Med, Div Pulm Med, Sch Med, Tokyo 1608582, Japan
[2] Keiyu Hosp, Div Pulm Med, Yokohama, Kanagawa 2200012, Japan
[3] Keio Univ, Dept Lab Med, Sch Med, Tokyo, Japan
[4] Keio Univ, Ctr Prevent Med, Sch Med, Tokyo 1608582, Japan
[5] Saitama Med Univ Hosp, Div Pulm Med, Saitama 3500495, Japan
[6] Tokai Univ, Dept Med, Div Pulm Med, Sch Med, Isehara, Kanagawa 2591193, Japan
关键词
comorbidity; COPD; echocardiography; pulmonary hypertension; COPD ASSESSMENT TEST; CLINICAL CHARACTERISTICS; COMPUTED-TOMOGRAPHY; OXYGEN-THERAPY; HEALTH-STATUS; EMPHYSEMA; ARTERY; IMPACT; RISK; HEMODYNAMICS;
D O I
10.2147/COPD.S230952
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary hypertension (PH) is a major comorbidity of chronic obstructive pulmonary disease (COPD). However, the association of PH detected by echocardiography and COPD-related outcome in longitudinal follow-up has not been elucidated. In this study, we aimed to investigate the relationship between clinical characteristics of COPD patients with PH detected by echocardiography and various outcome parameters such as COPD exacerbation and health status over a three-year observation period. Methods: In this observational study, we analyzed patients with COPD who underwent chest computed tomography and echocardiography at baseline (n = 183). Results: The prevalence of PH was 21.9% (40 patients). The median estimated systolic pulmonary artery pressure in patients with PH was 38.8 mmHg. COPD patients with PH were older, had a lower body mass index, scored worse in the COPD Assessment Test and St. George's Respiratory Questionnaire, and exhibited a lower diffusing capacity of the lung for carbon monoxide in comparison to patients without PH. In computed tomography images, the percentages of low-attenuation areas (LAA%) and interstitial abnormalities were higher in COPD patients with PH than in those without PH. Higher values for LAA % (LAA >= 30%) and interstitial abnormalities independently increased the risk of PH. The ratio of main pulmonary diameter to aortic artery diameter was significantly correlated with estimated systolic pulmonary artery pressure. In the follow-up analysis, the frequency of exacerbations in three years was significantly higher in patients with PH compared to patients without PH. Conclusion: In this study, we identified the clinical characteristics of COPD patients with PH detected by echocardiography. The presence of PH assessed by echocardiography was related to future COPD exacerbations and closely related to radiographical emphysema.
引用
收藏
页码:487 / 499
页数:13
相关论文
共 50 条
  • [21] Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure
    Beghe, Bianca
    Fabbri, Leonardo M.
    Garofalo, Martina
    Schito, Michela
    Verduri, Alessia
    Bortolotti, Monica
    Stendardo, Mariarita
    Ruggieri, Valentina
    Fucili, Alessandro
    Sverzellati, Nicola
    Della Casa, Giovanni
    Maietti, Elisa
    Clini, Enrico M.
    Boschetto, Piera
    RESPIRATION, 2019, 97 (03) : 223 - 233
  • [22] Sleep in hospitalized patients with chronic obstructive pulmonary disease: an observational study
    Stewart, Nancy H.
    Walters, Ryan W.
    Mokhlesi, Babak
    Lauderdale, Diane S.
    Arora, Vineet M.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2020, 16 (10): : 1693 - 1699
  • [23] Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study
    Wen-Ting Wu
    Chung-Yu Chen
    Scientific Reports, 10
  • [24] Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study
    Wu, Wen-Ting
    Chen, Chung-Yu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] Effects of Trimetazidine on patients with chronic obstructive pulmonary disease and pulmonary hypertension
    Oh, S. J.
    Yoon, S. J.
    Jeon, D. W.
    Yang, J. Y.
    Dk, C. H. O.
    EUROPEAN HEART JOURNAL, 2015, 36 : 963 - 963
  • [26] Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
    Chen, Chung-Yu
    Wu, Wen-Ting
    Wang, Ya-Ling
    Liao, Kuang-Ming
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [27] Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
    Sun Wan-Lu
    Wang Jian-Li
    Jia Guo-Hua
    Mi Wen-Jun
    Liao Yi-Xuan
    Huang Yong-Wei
    Hu Zheng
    Zhang Li-Qiang
    Chen Ya-Hong
    中华医学杂志英文版, 2019, 132 (11) : 1272 - 1282
  • [28] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
    Nicholas W Morrell
    Matthew A Higham
    Peter G Phillips
    B Haleema Shakur
    Paul J Robinson
    Ray J Beddoes
    Respiratory Research, 6
  • [29] Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
    Sun, Wan-Lu
    Wang, Jian-Li
    Jia, Guo-Hua
    Mi, Wen-Jun
    Liao, Yi-Xuan
    Huang, Yong-Wei
    Hu, Zheng
    Zhang, Li-Qiang
    Chen, Ya-Hong
    CHINESE MEDICAL JOURNAL, 2019, 132 (11) : 1272 - 1282
  • [30] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
    Morrell, NW
    Higham, MA
    Phillips, PG
    Shakur, BH
    Robinson, PJ
    Beddoes, RJ
    RESPIRATORY RESEARCH, 2005, 6 (1)